about
Present Advances and Future Perspectives of Molecular Targeted Therapy for OsteosarcomaTargeted Delivery Systems for Molecular Therapy in Skeletal DisordersProgress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery SystemsIn vivo screening for anti-osteoporotic fraction from extract of herbal formula Xianlinggubao in ovariectomized miceAptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy.miR-214 targets ATF4 to inhibit bone formation.Japanese medaka: a non-mammalian vertebrate model for studying sex and age-related bone metabolism in vivo.Bioinformatics and Microarray Analysis of miRNAs in Aged Female Mice Model Implied New Molecular Mechanisms for Impaired Fracture Healing.Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.Increased PLEKHO1 within osteoblasts suppresses Smad-dependent BMP signaling to inhibit bone formation during aging.Angiogenic factors in bone local environment.Src inhibitor reduces permeability without disturbing vascularization and prevents bone destruction in steroid-associated osteonecrotic lesions in rabbits.Targeting osteoblastic casein kinase-2 interacting protein-1 to enhance Smad-dependent BMP signaling and reverse bone formation reduction in glucocorticoid-induced osteoporosis.Deletion of estrogen receptor beta accelerates early stage of bone healing in a mouse osteotomy model.Therapeutic RNA interference targeting CKIP-1 with a cross-species sequence to stimulate bone formation.Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma.A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy.Bushen Yijing Fang Reduces Fall Risk in Late Postmenopausal Women with Osteopenia: A Randomized Double-blind and Placebo-controlled TrialA delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclastsRecent developments in bone anabolic therapy for osteoporosis
P50
Q26750631-88F4959D-42A8-4040-B2DE-4A9B09151BF7Q26752158-A05520F8-8419-4D20-A7E1-13808F6383C1Q26782485-D1B57391-4D39-4C55-8619-98B344908B61Q28543533-C4A40445-680D-4426-8421-8F60CD44835FQ33901933-9DDC664C-8988-4FE6-8DF5-24D9B2BB1B31Q34316430-A5792C74-90D4-47C7-8E0C-A3EB6BA7B115Q35093569-C11B6F9E-2B79-45B2-A008-05F443531D56Q37209989-CDC63C6A-A1BE-4B56-BE59-EF75676A1CE2Q37575983-20150954-C41D-4B11-BA08-6BF4A3BCD58FQ37678213-C8F740A6-9148-465C-B56B-9E5E2C708165Q38101152-0DEB98F1-828E-489C-85CE-63E371A9BAE1Q42145179-CE5EE2C7-6DC9-42AA-8D37-52F67343ED8EQ42188123-75BCE7D8-D07E-4456-8896-2D33567805B5Q42622705-23983C88-9D65-4FBA-8966-7B96AD51E188Q45242278-F8E945BE-EBA6-468A-B5BD-19849C3D4888Q49923005-E82535EE-5D48-485E-B928-AF07ABF1DF24Q54326868-D20F978A-F0F4-471A-B84D-08AD346C9A20Q61796223-B223257B-C135-4D6A-A579-585237907580Q87011673-A41D5E17-95E3-4074-89A5-EA612C9AC0B5Q91504717-0E170079-BC27-4616-BC44-AEDDD5B32412
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Baosheng Guo
@ast
Baosheng Guo
@en
Baosheng Guo
@es
Baosheng Guo
@nl
Baosheng Guo
@sl
type
label
Baosheng Guo
@ast
Baosheng Guo
@en
Baosheng Guo
@es
Baosheng Guo
@nl
Baosheng Guo
@sl
prefLabel
Baosheng Guo
@ast
Baosheng Guo
@en
Baosheng Guo
@es
Baosheng Guo
@nl
Baosheng Guo
@sl
P108
P106
P31
P496
0000-0002-4510-5418